Compare ATHM & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATHM | ATRC |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2013 | 2005 |
| Metric | ATHM | ATRC |
|---|---|---|
| Price | $21.97 | $45.75 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $28.00 | ★ $51.17 |
| AVG Volume (30 Days) | 710.1K | ★ 865.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 9.83% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | N/A | ★ $201,630,000.00 |
| Revenue This Year | N/A | $15.27 |
| Revenue Next Year | $4.77 | $12.21 |
| P/E Ratio | ★ $12.13 | $248.72 |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $15.57 | $25.36 |
| 52 Week High | $29.92 | $45.86 |
| Indicator | ATHM | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 50.07 | 79.15 |
| Support Level | $21.98 | $39.40 |
| Resistance Level | $22.24 | N/A |
| Average True Range (ATR) | 0.61 | 1.60 |
| MACD | -0.22 | 0.33 |
| Stochastic Oscillator | 33.54 | 93.87 |
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.